HARVARD MANAGEMENT CO INC - Q2 2018 holdings

Add to watchlist

$422 Million is the total value of HARVARD MANAGEMENT CO INC's 17 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 64.3% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
MSFT SellMICROSOFT CORP$135,173,000
-19.8%
1,370,779
-25.8%
32.05%
+55.2%
AAPL SellAPPLE INC$96,061,000
-66.2%
518,942
-69.3%
22.77%
-34.5%
MA NewMASTERCARD INCORPORATEDcl a$45,723,000–232,663
+100.0%
10.84%–
GOOGL NewALPHABET INCcap stk cl a$44,910,000–39,772
+100.0%
10.65%–
IVV SellISHARES TRcore s&p500 etf$20,830,000
+2.3%
76,285
-0.6%
4.94%
+98.2%
VEA SellVANGUARD TAX MANAGED INTL FDftse dev mkt etf$14,378,000
-3.5%
335,144
-0.4%
3.41%
+87.0%
GLD BuySPDR GOLD TRUST$12,021,000
+19.7%
101,314
+26.9%
2.85%
+131.9%
VWO SellVANGUARD INTL EQUITY INDEX Fftse emr mkt etf$8,578,000
-91.4%
203,276
-90.4%
2.03%
-83.3%
QQQ NewINVESCO QQQ TRunit ser 1$7,081,000–41,254
+100.0%
1.68%–
NTGN NewNEON THERAPEUTICS INC$6,374,000–505,871
+100.0%
1.51%–
IJH SellISHARES TRcore s&p mcp etf$5,508,000
+3.2%
28,278
-0.6%
1.31%
+100.0%
EDV BuyVANGUARD WORLD FDextended dur$5,250,000
+3.0%
45,765
+2.9%
1.24%
+99.5%
IJR SellISHARES TRcore s&p scp etf$5,215,000
+7.4%
62,491
-0.9%
1.24%
+108.1%
MGTA NewMAGENTA THERAPEUTICS INC$4,490,000–332,610
+100.0%
1.06%–
ADRO SellADURO BIOTECH INC$4,484,000
-67.3%
640,595
-56.6%
1.06%
-36.7%
VIG SellVANGUARD GROUPdiv app etf$3,036,000
+0.1%
29,879
-0.4%
0.72%
+94.1%
FB NewFACEBOOK INCcl a$2,693,000–13,860
+100.0%
0.64%–
QQQ ExitPOWERSHARES QQQ TRUSTunit ser 1$0–-36,045
-100.0%
-0.71%–
V ExitVISA INC$0–-399,594
-100.0%
-5.85%–
ExitALPHABET INCcap stk cl a$0–-128,958
-100.0%
-16.37%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2018-10-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR34Q3 202119.4%
VANGUARD TAX-MANAGED INTL FD34Q3 202114.0%
VANGUARD INTL EQUITY INDEX F34Q3 202112.2%
SPDR GOLD TRUST34Q3 20218.7%
ISHARES TR34Q3 20214.9%
META PLATFORMS INC29Q3 202337.6%
VANGUARD SPECIALIZED PORTFOL28Q1 20202.8%
MAGENTA THERAPEUTICS INC21Q2 20231.4%
ALPHABET INC19Q3 202330.4%
ISHARES TR19Q3 20214.4%

View HARVARD MANAGEMENT CO INC's complete holdings history.

Latest significant ownerships (13-D/G)
HARVARD MANAGEMENT CO INC Q2 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NuCana plcFebruary 12, 20211,678,2393.3%
ADURO BIOTECH, INC.February 08, 2019640,5950.8%
Fortress Transportation & Infrastructure Investors LLCSold outJuly 08, 201600.0%
Alpha Security Group CORPFebruary 13, 2009436,3005.8%
BLOCKBUSTER INCFebruary 13, 20095,567,1007.7%
ChinaGrowth North Acquisition CORPSold outFebruary 13, 200900.0%
ChinaGrowth South Acquisition CORPSold outFebruary 13, 200900.0%
GENEVA ACQUISITION CORPSold outFebruary 13, 200900.0%
Ideation Acquisition Corp.February 13, 2009310,2002.5%
MBF Healthcare Acquisition Corp.February 13, 20091,2200.0%

View HARVARD MANAGEMENT CO INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11
13F-HR2021-11-12

View HARVARD MANAGEMENT CO INC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export HARVARD MANAGEMENT CO INC's holdings

CSVXLS